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intestinal barrier function is 
maintained with aging – a 
comprehensive study in healthy 
subjects and irritable bowel 
syndrome patients
ellen Wilms  1,2*, Freddy J. troost1,3, Montserrat elizalde1, Bjorn Winkens  4, Paul de Vos2,5, 
Zlatan Mujagic1, Daisy M. A. E. Jonkers1 & Ad A. M. Masclee1
Animal studies have shown that intestinal barrier function is compromised with aging. We aimed to 
assess the effects of aging on intestinal barrier function in humans in vivo and ex vivo. In this cross-
sectional study, healthy subjects and subjects with irritable bowel syndrome (IBS) of older (65–75 years) 
and young adult age (18–40 years) were compared. In vivo gastrointestinal site-specific permeability 
was assessed by a multi-sugar test, taking into account potential confounders. Sigmoid biopsies were 
collected from subgroups of healthy young adults and elderly for ex vivo Ussing chamber experiments, 
gene transcription of barrier-related genes and staining of junctional proteins. No significant differences 
between healthy young adults and elderly were found for small intestinal, colonic and whole gut 
permeability (P ≥ 0.142). In IBS patients, gastroduodenal and colonic permeability did not differ 
significantly (P ≥ 0.400), but small intestinal and whole gut permeability were higher in elderly versus 
young adults (P ≤ 0.009), mainly driven by the IBS-diarrhea subtype. Ussing chamber experiments 
with or without stressor (P ≥ 0.052), and relative expression of intestinal barrier-related genes 
(P ≥ 0.264) showed no significant differences between healthy elderly and young adults, as confirmed 
by immunofluorescent stainings. Overall, the functional capacity of the intestinal barrier is maintained 
in elderly.
Along with the rising life expectancy, the aging population is steadily increasing worldwide. In 2010, 8% of the 
world population was aged 65 years or older, and this proportion is expected to reach 16% by 2050, leading to 
substantial increases in direct and indirect health care costs1. The associated functional decline of several organs 
and tissues, including those of the gastrointestinal (GI) tract and the immune system, contributes to higher vul-
nerability to infections with aging and age-related co-morbidities2,3. With respect to GI physiology and function, 
a recent review by our group showed that the aging process is associated with small, subtle alterations at both 
the organ and cellular level4. Moreover, the GI mucosal immune function has been found to decline with aging5. 
Based on data of mice, rat and baboon studies it has been stated that intestinal barrier function also decreases 
with aging, as reflected by an increased paracellular intestinal permeability6–9. Intestinal permeability is an impor-
tant functional feature of the intestinal epithelial barrier10. Increased intestinal permeability may lead to perme-
ation of noxious luminal substances into the intestinal mucosa, inducing local and systemic immune activation, 
and may contribute to e.g. an increased infection risk, inflammation, and GI symptoms. So far, a few human stud-
ies have investigated the effects of aging on small intestinal or colonic barrier function. In these studies, most of 
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which addressed the small intestine, no differences in sugar excretion ratios between age groups were found11–14. 
However, the impact of potential confounders such as medication use (e.g. proton pump inhibitors (PPIs) and 
non-steroidal anti-inflammatory drugs (NSAIDs)) have not been considered in previous studies, while these 
drugs are widely used by elderly and less in younger adults. Futhermore, most studies on aging focused on healthy 
subjects, while it may be also valuable to get insight in barrier function in subjects with mild disturbances in GI 
health, such as irritable bowel syndrome (IBS) patients, in whom intestinal barrier disfunction has been shown 
previously15, but has not been studies with regard to age. Paracellular permeability is regulated by intercellular 
junctional complexes16. At present, data from human studies with regard to aging on the expression and function 
of tight junction proteins, sealing the epithelial barrier, are not available.
In summary, available data on the effects of aging on the intestinal barrier in humans are very limited and 
when present, often conflicting17. Therefore, a comprehensive study on the effects of aging on intestinal barrier 
function is needed. Our aim was to study the effects of aging on human intestinal barrier function in combined 
in vivo and ex vivo experiments, by determining GI permeability and the expression of barrier related genes. We 
hypothesized that intestinal permeability is increased and the expression of intestinal barrier related genes is 
lower in elderly compared with young adults, in both healthy subjects and IBS patients.
Results
intestinal permeability in vivo. Assessment of intestinal permeability in vivo by the multi-sugar test was 
performed in 100 healthy individuals including 48 elderly and 52 young adults, as well as in 48 IBS patients 
including 21 elderly and 27 young adults. Subject characteristics are shown in Table 1. BMI (P < 0.001) and PPI 
use (P = 0.017) were significantly higher in healthy elderly compared with healthy young adults.
Gastroduodenal permeability as assessed by the 0–5 h urinary sucrose excretion was lower in healthy elderly 
compared with young healthy adults (P = 0.025), but did not differ significantly between elderly and young IBS 
patients (P = 0.400) (Fig. 1A,B, respectively). The 0–5 h urinary L/M ratio reflecting small intestinal permeability 
in healthy subjects was not significantly different between elderly and young adults (P = 0.214) (Fig. 1C), while 
in the IBS group, small intestinal permeability as determined by the 0–5 h urinary L/R ratio was higher in elderly 
compared with young adults (P = 0.009) (Fig. 1D).
Colonic permeability in vivo as determined by the 5–24 h urinary S/E ratio was not significantly different 
between healthy elderly and healthy young adults (P = 0.227), nor between elderly and young IBS patients 
(P = 0.664) (Fig. 2A,B, respectively). The 0–24 h urinary S/E ratio, as measure for whole gut permeability in 
vivo, is not significantly different between healthy elderly and healthy young adults (P = 0.061), whereas in IBS 
patients, the 0–24 h urinary S/E ratio was higher in elderly compared with young adults (P = 0.003) (Fig. 2C,D, 
respectively).
As demographics and medication use may influence intestinal permeability in vivo, their impact was 
accounted for by multivariable linear regression analysis as shown in Supplementary Tables S2 (healthy indi-
viduals) and S3 (IBS patients). In healthy individuals, the 0–5 h urinary sucrose excretion (B = −16.430 (95% 
CI −35.855; 2.996)), 0–5 h urinary L/M ratio (B = −0.051 (95% CI −0.140; 0.038)) and 0–24 h urinary S/E ratio 
(B = −0.025 (95% CI −0.011; 0.060)) were not significantly affected by age group (elderly vs. young adults). 
However, healthy elderly had on average a significantly higher 5–24 h urinary S/E ratio (B = 0.030 (95% CI 0.001; 














mean ± SD) 23.1 ± 4.3 69.7 ± 2.8 <0.001 29.4 ± 6.5 71.1 ± 4.0 <0.001
Female (%) 57.7 43.8 0.164 59.3 66.7 0.599
BMI (kg/m2, 
mean ± SD) 22.9 ± 2.7 25.8 ± 2.7 <0.001 25.4 ± 5.2 25.5 ± 3.2
# 0.896
Medication (%)
PPI 0 10.4 0.017 26.9# 14.3 0.293
NSAID N.A N.A. N.A. 7.7# 23.8 0.123
IBS subtype (%)
IBS-C 18.5 28.6 0.412
IBS-D N.A. N.A. N.A. 40.7 38.1 0.849
IBS-M 37.0 28.6 0.535
IBS-U 3.7 4.8 0.857
Table 1. Subject characteristics per age group of the healthy individuals and IBS patients undergoing the 
multi-sugar test for in vivo assessment of the intestinal permeability. BMI: body mass index, IBS: irritable bowel 
syndrome, IBS-C: constipation-predominant irritable bowel syndrome, IBS-D: diarrhea-predominant irritable 
bowel syndrome, IBS-M: irritable bowel syndrome characterized by a mixed pattern, IBS-U: Unsubtyped 
irritable bowel syndrome, N.A: not applicable, NSAID: nonsteroidal anti-inflammatory drugs, PPI: proton-
pump inhibitors. Age and BMI were compared between age groups with the use of an independent samples 
t-test. Sex, medication and IBS subtype were compared between age groups with the use of a Pearson Chi-
square test. #One missing value for this variable.
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CI −5.549; 8.331)) as well as 0–5 h urinary L/R ratio (B = 0.007 (95% CI −0.006; 0.020)), 5–24 h urinary S/E ratio 
(B = 0.040 (95% CI −0.021; 0.101)) and 0–24 h urinary S/E ratio (B = 0.066 (95% CI −0.021; 0.153)) were not 
significantly influenced by age group (elderly vs. young adults).
Sex, BMI and PPI use did not significantly affect urinary sugar excretions and ratios in the healthy subjects 
(Supplementary Table S2). In IBS patients, the 0–5 h urinary sucrose excretion, 5–24 h urinary S/E ratio and 0–24 h 
urinary S/E ratio were also not significantly influenced by PPI use, NSAID use or IBS subtype (Supplementary 
Table S3). However, diarrhea-predominant irritable bowel syndrome (IBS-D) patients had on average a significantly 
higher 0–5 h urinary L/R ratio (B = 0.018 (95% CI 0.004; 0.031)) compared with other subtypes.
intestinal permeability ex vivo. Ussing chamber experiments were performed to study TEER and lumi-
nal fluorescein concentration as functional indicators of paracellular permeability, in unstressed and stressed 
biopsies of 10 healthy elderly (mean ± SD: 70.7 ± 2.8 yrs) and 10 healthy young adults (24.0 ± 5.4 yrs). Mean BMI 
was found to be significantly higher in elderly (27.3 ± 1.7 kg/m2) compared with young adults (23.4 ± 3.2 kg/m2; 
P = 0.005). Sex, PPI use and NSAID use did not differ significantly between elderly (20% female, 20% PPI use, 
0% NSAID use) and young adults (30.0% female, 0% PPI use, 0% NSAID use; all P ≥ 0.136). After FDR correc-
tion for multiple time points, TEER did not significantly differ between elderly and young adults in unstressed 
(all P ≥ 0.208), nor in stressed biopsies (all P ≥ 0.096) (Fig. 3A,B, respectively). In both unstressed biopsies (all 
P ≥ 0.052) and stressed biopsies (all P ≥ 0.760), luminal fluorescein concentration did not differ significantly 
between elderly and young adults (Fig. 3C,D, respectively).
Gene transcription of barrier related genes. Relative expression of junctional complex (e.g. tight 
junctions and adherens junctions), defense and immune-related (e.g. human defensins, cytokines and toll-like 
receptor) genes in sigmoid biopsies were studied because these are directly or indirectly related to paracellular 
permeability and barrier function in general. Before correcting for multiple testing, only cadherin 1 (P = 0.047) 
was higher and toll-like receptor 1 (P = 0.024) was lower in healthy elderly compared with healthy young adults. 
After correcting for multiple testing, there were no significant differences (all P ≥ 0.264) between healthy elderly 
and healthy young adults in the relative expression of junctional complex, defense and immune-related genes 
(Table 2).
Figure 1. Gastroduodenal and small intestinal permeability in vivo comparing young adults vs. elderly. (A) 
0–5 h urinary sucrose excretion in healthy individuals. (B) 0–5 h urinary sucrose excretion in IBS patients. (C) 
0–5 h urinary lactulose/mannitol ratio in healthy individuals. (D) 0–5 h urinary lactulose/rhamnose ratio in IBS 
patients. Values are presented in scatter plots with median line and IQR (25–75th interquartile range). Urinary 
sugar excretions and ratios were compared between age groups with the use of Mann-Whitney U-tests.
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Immunofluorescent stainings of TJP1 (ZO-1) and occludin. Representative images of immunoflu-
orescent staining TJP1 (ZO-1) and occludin in sigmoid biopsy sections of a healthy elderly and healthy young 
adult are presented in Fig. 4. TJP1 (ZO-1) and occludin showed continuous staining without disruption along the 
villous epithelium. No apparent differences were noted between the elderly and young adults. These observations 
are in line with quantitative analyses of TJP1 (ZO-1) and occludin gene transcription levels as reported in Table 2.
Discussion
In this study, we evaluated various, different and complementary aspects of GI barrier function to assessed the 
effects of aging in humans. Overall, GI segment-specific permeability and expression of barrier-related genes 
were not significantly affected by aging in healthy individuals. In IBS, a condition which is generally considered 
to be associated with mild alterations in gut function, small intestinal permeability was higher in the elderly. This 
difference was partly explained by the IBS-D subtype. We therefore rejected the study hypothesis that intestinal 
barrier function and the expression of barrier related genes is altered with aging per se in healthy subjects and in 
mild GI disorders.
Up to now, previous studies on aging and intestinal permeability in vivo have been critically debated because 
of methodological issues. One study11 included a heterogeneous group of patients and hospital staff. In two other 
studies12,13 high dosages of mannitol (5 g) and lactulose (10 g) were used, which is in this dosage considered a 
laxative, and therefore probably inducing osmotic effects18. We applied the validated multi-sugar test, using low 
sugar dosages (0.5–1 g per sugar probe), to determine site-specific paracellular intestinal permeability in vivo in 
well defined groups of healthy individuals and IBS patients, taking into account factors potentially influencing 
these parameters. Gastroduodenal permeability was determined by assessing urinary sucrose excretion in the 
0–5 h fasting period of the multi-sugar test. Urinary sucrose excretions were significantly lower in the healthy 
elderly compared with healthy young adults. Although we cannot exclude that this may in part be due to more 
outliers in the young adults group than in the elderly, age group was not significant in the multivariable linear 
regression analysis by correcting for potential confounders. Therefore our findings are in line with previous find-
ings in healthy adults19,20 and indicating the initial difference in gastroduodenal permeability should be inter-
preted with caution. Moreover, in elderly and young adult IBS patients we observed a comparable gastroduodenal 
Figure 2. Colonic and whole gut permeability in vivo comparing young adults vs. elderly. (A) 5–24 urinary 
sucralose/erythritol ratio in healthy individuals. (B) 5–24 urinary sucralose/erythritol ratio in IBS patients. (C) 
0–24 urinary sucralose/erythritol ratio in healthy individuals. (D) 0–24 urinary sucralose/erythritol ratio in IBS 
patients. Values are presented in scatter plots with median line and IQR (25–75th interquartile range). Urinary 
sugar ratios were compared between age groups with the use of Mann-Whitney U-tests.
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permeability. To the best of our knowledge, this is the first study investigating gastroduodenal permeability and 
aging. A clear reason for the outliers in the healthy young adults is lacking, but it should be acknowledged that 
urinary sucrose excretion was not corrected for potential differences in for example transit time or renal clearance 
as no transcellar probe was available to correct for. Although some debates are ongoing on the optimal timing 
of urine collection, in the current study the 0–5 urinary L/R ratio and L/M ratio used in the current study are 
considered to reflect small intestinal permeability in healthy and IBS individuals, respectively. As medians of 
0–5 h urinary L/R and L/M ratios were in the same range, the impact of using different disaccharides as a trans-
cellar probe indeed seemed negligible. We showed that small intestinal permeability did not differ significantly 
between healthy elderly and healthy young adults, which is in line with previous observations in healthy indi-
viduals12,13. In IBS patients however, small intestinal permeability was higher in elderly compared with young 
adults. Furthermore, we showed that the IBS-D subtype was associated with an increased small intestinal per-
meability in these elderly, confirming previous observations of the Maastricht IBS cohort15 and others21,22. This 
indicates that the observed increase was not due to the aging per se. Using univariate non-parametric com-
parisons (i.e. Mann-Whitney U-tests), no significant differences were found in colonic permeability as meas-
ured by the 5–24 h urinary S/E ratio between elderly and young adults neither in healthy individuals, nor in 
IBS patients. These findings are largely in line with the comparable 5–24 h urinary S/E ratios between elderly 
without GI symptoms and younger healthy individuals and as shown by Ganda Mall et al.14. However, paramet-
ric, multivariable linear regression analyses showed that healthy elderly had on average a significantly higher 
5–24 h urinary S/E ratio compared with healthy young adults. This was caused by a higher sucralose flux (data 
not shown), pointing towards a slightly increased paracellular permeability. The colon harbors a complex dense 
environment of not only beneficial microbes, but also potentially harmful microbes and antigens. Maintaining 
a well-functioning colonic barrier function with aging is advantageous since it will limit permeation of such 
components into the intestinal mucosa, and prevent mucosal damage, local and systemic immune activation. 
The 0–24 h urinary S/E ratio, reflecting whole gut permeability, did not differ significantly between elderly and 
Figure 3. Intestinal permeability ex vivo comparing healthy young adults vs. healthy elderly by mounting 
fresh sigmoid colon biopsies in an Ussing chamber system, and assessing transepithelial electrical resistance 
(TEER) and luminal fluorescein concentration at t = 0, t = 30, t = 60, t = 90, t = 120 min. (A) TEER in 
unstressed biopsies. (B) TEER in biopsies stressed by 1 µg/ml Compound 48/80 at t = 0. (C) Luminal fluorescein 
concentration in unstressed biopsies. (D) Luminal fluorescein concentration in biopsies stressed by 1 µg/ml 
Compound 48/80 at t = 0. In the young adult group, two subjects were removed from the unstressed biopsy 
analyses, and three subjects were removed from the stressed biopsy analyses because baseline values were not 
meeting the quality criteria for viability. Means and standard deviations are visualized. TEER and luminal 
fluorescein were compared between age groups using random intercept linear mixed model analyses including 
age group, time and age group x time as fixed factors and correction for t = 0 values. P-values per time point 
were corrected for multiple testing by calculating the false-discovery-rate (FDR) of Benjamini-Hochberg.
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healthy young adults, but in IBS patients a higher whole gut permeability was observed in elderly compared with 
young adults. This can at least partly be explained by the observed effect of aging on small intestinal permeability 
in the diarrhea-predominant IBS patients. In the current study, sugar ratios were used to correct for e.g. transit 
time and renal clearance. Additionally, to determine intestinal permeability ex vivo as well as the susceptibility 
to a stressed condition, Ussing chamber experiments with sigmoid biopsies of a subgroup of healthy individu-





P-valueN Mean SD N Mean SD
Junctional complex related genes
TJP1 (ZO-1) 10 1.13 0.03 10 1.14 0.02 0.641 0.673
OCLN 10 1.18 0.02 10 1.19 0.02 0.314 0.673
CLDN2 5 1.36 0.03 6 1.32 0.07 0.269 0.673
CLDN3 10 1.16 0.02 10 1.17 0.02 0.556 0.673
CLDN4 10 1.10 0.02 10 1.11 0.02 0.673 0.673
MLCK 10 1.15 0.03 10 1.15 0.03 0.534 0.673
CDH1 10 1.15 0.01 10 1.17 0.02 0.047 0.376
CTNNB1 10 1.12 0.01 10 1.13 0.02 0.386 0.673
Defense and immune related genes
CAMP 9 1.30 0.05 10 1.28 0.06 0.462 0.726
DEFB1 10 1.15 0.03 10 1.16 0.03 0.951 0.951
MUC2 10 1.01 0.03 10 1.01 0.02 0.559 0.769
TFF3 10 0.98 0.04 10 0.98 0.04 0.898 0.951
IL1B 10 1.35 0.05 9 1.32 0.04 0.233 0.667
IL10 9 1.25 0.03 9 1.23 0.06 0.300 0.667
TNF 9 1.35 0.06 5 1.34 0.04 0.805 0.951
TLR1 10 1.18 0.04 10 1.13 0.04 0.024 0.264
TLR2 9 1.26 0.05 10 1.23 0.06 0.354 0.667
TLR4 10 1.21 0.03 10 1.19 0.03 0.063 0.347
TLR6 8 1.29 0.04 7 1.27 0.06 0.364 0.667
Table 2. Relative expression of junctional complex (e.g. tight junction related and adherens junctions), defense 
and immune related (e.g. human defensins, cytokines and toll-like receptor) genes in sigmoid biopsies of young 
adults and elderly. TJP1 (ZO-1): Tight junction protein 1 (i.e. Zona Occludens-1), OCLN: Occludin, CLDN: 
Claudin, MLCK: Myosin light chain kinase, CDH1: Cadherin 1, CTNNB1: Catenin beta 1, CAMP: Cathelicidin 
antimicrobial peptide, DEFB1: Defensin beta 1, MUC2: Mucin 2, TFF3: Trefoil factor 3, IL: Interleukin,, TNF: 
Tumor necrosis factor, TLR: Toll like receptor. GAPDH was used as reference gene. Values are presented 
as mean ± SD. Differences between age groups were tested by independent-samples T Tests. P-values were 
corrected for multiple testing by calculating the false-discovery-rate of Benjamini Hochberg per cluster.
Figure 4. Representative images of tight junction proteins TJP1 (ZO-1) (green) and occludin (red) 
immunofluorescent stainings in sigmoid biopsy sections showing glandular epithelium of a healthy young 
adult and healthy elderly. Scale bar represents 100 µm. Blue counterstaining (DAPI) shows nuclei. TJP1: Tight 
junction protein 1.
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were not significantly different between elderly and young adults. To our knowledge, one other study compared 
sigmoid biopsies of elderly with GI symptoms versus young healthy controls, and found no significant difference 
in TEER, although fluorescein flux and horseradish peroxidase (HRP) were significantly higher in elderly with 
GI symptoms compared with healthy controls14. Unfortunately, no biopsies of IBS patients were available for 
Ussing chamber experiments. Moreover, a human study by Man et al. performed Ussing chamber experiments in 
unstressed ileum biopsies and found that TEER values were significantly lower in healthy elderly (67–77 yrs) com-
pared with healthy adults (20–40 yrs), while HRP flux remained unchanged23. TEER does also reflect transcel-
lular ion transport and thereby does not necessarily indicated alterations in the junctional complex. Differences 
between the locations of tissue sampling between the previously reported observations and the current study, the 
ileum and the colon, respectively, further impede direct comparison of the results. We used sigmoid biopsies to 
limit the invasiveness for the subjects and as a tightly controlled permeability is considered especially important 
in the colon with its high bacterial load. We did apply a mild physiological relevant stressor (1 µg/ml Compound 
48/80), which resulted in an average increase in luminal fluorescein concentrations of 28.7% and average decrease 
in TEER of 13.2% after 120 minutes (data not shown) to check for a potential increased susceptility to stressed 
conditions. In the by Compound 48/80 mildly stressed biopsies, no differences were observed between young 
adults and elderly in in TEER and luminal fluorescein concentrations. This point towards a maintained adaptive 
capacity of the tissue samples with aging.
Relative expression levels of genes related to the junctional complex, innate and adaptive immunity and bar-
rier function in general, as analyzed by qPCR, showed no significant differences between healthy adults and 
healthy elderly after FDR correction. These observations were supported by immunofluorescent stainings of TJP1 
(ZO-1) and occludin in representative colon biopsy sections, confirming that the junctional complex seems to 
remain intact with aging. In the study by Man et al., claudin-2 and IL-6 expression levels were found to be higher 
in ileum biopsies of elderly (67–77 yrs) compared with young adults (20–40 yrs), but no changes were found in 
TJP1 (ZO-1), occludin, JAMA-1, IFN-γ, IL-1β and TNF-α23. In that study, while testing a relativly large number 
of genes, the results were not corrected for multiple testing and therefore should be interpreted with care. In the 
current study corrections for multiple testing were applied and we show no statistically signicant differences 
between age groups. Secondly, findings of the ileum and sigmoid colon are difficult to compare because junctional 
complexes are stronger in the colon compared with small intestine. Lastly, the intestinal barrier is not static, but 
constantly remodeling in order to selectively regulate intestinal permeability. For example, TJP1 (ZO-1) stabi-
lizes claudin strands and tightens them to the actin cytoskeleton. Therefore, single gene expression needs to be 
interpreted with care. In the current study, we investigated a broad range of junctional complex-related genes 
showing no significant differences with aging. The intestinal barrier is not only formed by the epithelial layer, but 
includes overlying mucus and produces for example antimicrobial proteins. Therefore we analyzed innate defense 
and immune related genes, but these did not differ significantly between healthy adults and elderly. Overall, our 
findings in ex vivo experiments are in line with the measured in vivo intestinal permeability.
The strength of the current study is that the effects of aging on gastroduodenal, small intestinal and colonic 
permeability were investigated in distinct age groups of healthy individuals and IBS patients using a combined in 
vivo and ex vivo approach, enabling to study functional as well as structural aspects of intestinal barrier function. 
This study showed that intercellular junctional functionality regulating paracelular permeation, was maintained 
with aging in both healthy individuals and IBS patients. Only small intestinal permeability was increased in 
IBS-D, independent of age. Moreover, the expression of barrier related genes was comparable between healthy 
elderly and healthy young adults. Intact intestinal permeability regulation can prevent permeation of noxious 
luminal substances into the intestinal mucosa, with subsequent local and systemic immune activation. In conclu-
sion, although age-related factors such as medication use and co-morbidities may impact barrier function, we did 
not find an indication for impaired intestinal permeability in aging per se.
Methods
Study design and participants. In this cross-sectional study, baseline data of healthy individuals who 
participated in a human intervention study, and of IBS patients of the Maastricht IBS cohort15 were used. Both 
studies were approved by the Medical Ethics Committee of the University Hospital Maastricht and Maastricht 
University, were registered in the US National Library of Medicine (http://www.clinicaltrials.gov, NCT02376270 
and NCT00775060, respectively), and performed between November 2009 and April 2016, in accordance with the 
Declaration of Helsinki (latest amendment in Fortalesa, Brasil, 2013) and Dutch Regulations on Medical Research 
involving Human Subjects (1998). Healthy individuals were recruited by public advertisements and key exclusion 
criteria were GI diseases, abdominal surgery interfering with GI function, pregnancy, and use of medication 
influencing intestinal permeability such as NSAIDs. IBS patients were recruited via the Maastricht University 
Medical Center + Gastroenterology-Hepatology outpatient clinic and via regional general practices, and were 
diagnosed and classified by the Rome III criteria with exclusion of organic diseases when indicated, as described 
previously15. To assess the effects of aging, two groups were included in both the healthy and the IBS populations: 
i.e. elderly 65–75 years and young adults 18–40 years to create distinct age groups (Fig. 5). All participants gave 
written informed consent before participation.
Outcome parameters. In the current study, various, different and complementary measurements of barrier 
function were measured (Fig. 5). All healthy and IBS individuals were subjected to a standardized and validated 
multi-sugar urinary recovery test to assess GI segment-specific intestinal permeability in vivo. From a subgroup 
of the healthy subjects (10 elderly and 10 young adults) colonic biopsies were collected for ex vivo analyses of 
intestinal permeability by Ussing chamber experiments as well as for gene and protein analyses of intestinal bar-
rier related proteins. These subjects underwent flexible sigmoidoscopy without bowel preparation. Biopsy speci-
mens were taken with a jumbo biopsy forceps (Boston Scientific, Kerkrade, the Netherlands) from a standardized 
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location, i.e. 30 cm proximal to the anus. Six tissue samples were immediately transported to the laboratory for 
Ussing chamber experiments. One tissue sample was snap frozen in liquid nitrogen and stored at −80 °C for gene 
transcription analyses. One tissue sample was mounted in Tissue-Tek® optimal cutting temperature compound 
(Sakura, Finetek, Tokio, Japan), snap frozen in liquid nitrogen and stored at −80 °C for immunofluorescent stain-
ing of Tight junction protein 1 (TJP1; i.e. Zona Occludens-1) and occludin.
Multi-sugar test for analysis of intestinal permeability in vivo. Segment-specific permeability of 
the GI tract was assessed with a validated multi-sugar test18,24. On the day prior to, as well as during the test, 
subjects were asked to refrain from excessive physical exercise and consumption of alcohol. After fasting over-
night, a mix of water-soluble sugar probes were ingested. IBS patients ingested 1 g sucrose (Van Gilse, Dinteloord, 
the Netherlands), 1 g lactulose (Centrafarm Services, Etten-Leur, the Netherlands), 0.5 g L-rhamnose (Danisco, 
Copenhagen, Denmark), 1 g sucralose (Tate and Lyle Ingredients Americas, Decatur, IL, USA) and 1 g erythri-
tol (Now Foods, Bloomindale, IL, USA), dissolved in 200 ml tap water. Healthy individuals ingested the same 
mixture, except for 0.5 g mannitol (Roquette, Lestrem, France) instead of L-rhamnose. It was not possible to 
use L-rhamnose as permeation marker in that study, as the subsequent intervention from which these baseline 
data were obtained entailed supplementation with pectin, a non digestible carbohydrate that contains rhamnose 
residues. These residues would have interfered with a multisugar urinary recovery test containing L-rhamnose. 
Mannitol and L-rhamnose are both disaccharides with the same intestinal permeation characteristics, therefore 
we do not expect this to hinder comparability of the data. After ingestion, all participants collected 24 hours (h) 
urine in two separate fractions; 0–5 h and 5–24 h. During the first 5 h of urine collection, participants were asked 
to refrain from any food or drinks, except for water ad libitum. Thereafter, participants were allowed to eat and 
drink as preferred, except for sucralose containing foods. After the collection periods, volumes of urine frac-
tions were determined and aliquots were frozen at −80 °C until analysis. Sugar probes were analyzed by isocratic 
ion-exchange High Performance Liquid Chromatography with mass spectrometry as described previously18,24. 
Gastroduodenal permeability was determined by sucrose excretion in 0–5 h urine, small intestinal permeability 
by 0–5 h urine lactulose to mannitol (L/M) ratio in healthy individuals and lactulose to rhamnose (L/R) ratio in 
IBS patients, colonic permeability by sucralose to erythritol (S/E) ratio in 5–24 h urine, and whole gut permeabil-
ity by sucralose to erythritol (S/E) ratio in 0–24 h urine.
Ex vivo ussing chamber experiments. Six tissue samples from the sigmoid colon were used for ex 
vivo Ussing chamber experiments as previously described by our group25. Three tissue samples were stressed 
by adding mast cell degranulator Compound 48/80 (1 µg/ml, Sigma-Aldrich, St. Louis, MO, USA) to the ser-
osal compartment. Three non-exposed tissue samples served as controls. At t = 0, 1 mg/ml fluorescein (376 g/
mol, Sigma-Aldrich, St. Louis, MO, USA) was added to the serosal compartment. Potential difference (PD), 
Transepithelial electrical resistance (TEER) and luminal fluorescein concentrations were determined at time 
point t = 0, 30, 60, 80 and 120 min, respectively. TEER and PD were used as quality criteria for viability. Only 
samples with a baseline TEER above 20 Ω/cm2, or those with baseline TEER between 15–20 Ω/cm2 and PD below 
0.5 mV, were included for analyses. Lower TEER values and higher fluorescein concentrations are indicators of 
impaired intestinal permeability.
Gene transcription of barrier-related genes. Transcription of junctional complex related genes as well 
as defense and immune related genes associated with barrier function or modulation thereof, were determined 
in colonic tissue samples. Nucleic acid extraction and purification, RNA isolation and reverse transcription 
Healthy individuals IBS patients
Young adults Young adultsElderly Elderly




    - Ussing chamber experiments 
    - Barrier-related genes
    - Immunofluorescence staining 
      of TJP1 and occludin
Subject characteristics
Multi-sugar test
Figure 5. Overview of the study population and measurements.
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were performed as previously described26. Depending on the gene of interest, cDNA was diluted to final con-
centrations of 20 ng/µl, 40 ng/µl or 80 ng/µl (Supplementary Table S1). Quantitative real-time polymerase chain 
reaction (qPCR) was performed as described previously27. Expressions of target genes were normalized to 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as reference gene.
Immunofluorescent staining of TJP1 (ZO-1) and occludin. Sigmoid biopsy sections (10 µm) were 
used for immunofluorescent staining of TJP1 (ZO-1) and occludin as previously described by Elamin et al.28.
Statistical analyses. This is considered a first human study applying the multi-sugar test in combination 
with ex vivo analyses. We made use of existing data sets to investigate the effects of aging on intestinal permeabil-
ity. The results of this study will enable future power calculations in this field, especially because of the comple-
mentary range of parameters to determine intestinal barrier function.
Missing data was not imputed, but reported upon in the results. We checked for normality of the data (histo-
grams) and subsequently variables were summarized using median and interquartile range (IQR; 25–75th IQR) 
or means ± standard deviation for numerical variables, and percentages for categorical variables. Mann-Whitney 
U-tests and independent-samples T Tests were performed for numerical variables and Chi-square tests for cat-
egorical variables to test for differences between age groups (elderly versus young adults). Factors potentially 
influencing intestinal permeability in vivo were tested by multivariable linear regression analysis. These regression 
models included age group, sex, body mass index (BMI), and PPI use for healthy individuals, and age group, 
PPI use, NSAID use, and IBS subtype for IBS patients. Differences in longitudinal trends in TEER and luminal 
fluorescein between age groups were assessed by random intercept linear mixed model analyses with age group 
(elderly and young adult), time (t = 0, t = 30, t = 60, t = 90, t = 120 min) and ‘age group x time’ as fixed factors, 
and correction for t = 0 values. All statistical analyses were performed using IBM SPSS Statistics for Windows 
(version 25.0, Armonk, NY, USA: IBM Corp.). P-values ≤ 0.05 (two-sided) were considered statistically signif-
icant. Ussing chamber experiments and gene transcription P-values were corrected for multiple testing by the 
false-discovery-rate (FDR) of Benjamini-Hochberg.
Data availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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